文献速递传染病防控与疫情报告环境卫生

ONRAB口服狂犬病疫苗在圈养哺乳动物中可排出但不持续存在

ONRAB® oral rabies vaccine is shed from, but does not persist in, captive mammals.
PubMed 文献 · Vaccine · 2019-06-24

本研究评估ONRAB口服狂犬病疫苗病毒在圈养狂犬病媒介动物和非目标哺乳动物中的持续性。动物经口接种疫苗后,用定量实时PCR监测口腔和直肠拭子中的疫苗DNA。大多数动物在接种后6小时至3天检测到疫苗DNA,部分物种在17至34天出现再次排出,但至第41天所有动物拭子均未检出DNA。结果表明ONRAB在暴露的媒介和非目标哺乳动物中不持续存在。

要点

  • ONRAB疫苗DNA在多数动物接种后6小时至3天于口腔和直肠拭子中检出。
  • 部分物种在接种后17至34天出现疫苗DNA排出再次出现。
  • 至第41天所有动物口腔和直肠拭子均未检出疫苗DNA。

核心结论

  • ONRAB口服狂犬病疫苗病毒在圈养狂犬病媒介和非目标哺乳动物中可排出但不持续存在。
  • 数据反映将ONRAB用于控制森林狂犬病对野生种群的不良影响风险低。

研究设计与样本

  • 研究检测ONRAB疫苗病毒在圈养狂犬病媒介和非目标哺乳动物中的持续性。
  • 动物经口直接接种疫苗,用定量实时PCR检测口腔和直肠拭子中的疫苗DNA。
  • 监测期延长至接种后41天。
  • 研究补充了浣熊、条纹臭鼬和红狐等媒介物种以及弗吉尼亚负鼠、挪威鼠和棉鼠等非目标物种的数据。

主要发现

  • 大多数动物在接种后6小时至3天于口腔和直肠拭子中检出ONRAB DNA。
  • 部分物种在接种后17至34天出现疫苗DNA排出再次出现。
  • 非目标哺乳动物中ONRAB DNA可检出持续时间较短。
  • 至第41天所有动物口腔和直肠拭子均未检出ONRAB DNA。
  • 所有目标物种以及棉鼠和实验室繁育挪威鼠通过竞争性ELISA检测均产生强 humoral 免疫应答,第31天所有个体血清阳性。

关键数值与推荐

  • 负鼠第31天血清阳性率为89%(8/9)。
  • 野生捕获挪威鼠第31天仅九分之一血清阳性。

临床怎么用

  • 支持ONRAB口服狂犬病疫苗在野生动物中分发控制狂犬病时对非目标哺乳动物不良影响风险低的判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ONRAB® is a human adenovirus rabies glycoprotein recombinant vaccine developed to control rabies in wildlife. To support licensing and widespread use of the vaccine, safety studies are needed to assess its potential residual impact on wildlife populations. We examined the persistence of the ONRAB® vaccine virus in captive rabies vector and non-target mammals. This research complements work on important rabies vector species (raccoon, striped skunk, and red fox) but also adds to previous findings with the addition of some non-target species (Virginia opossum, Norway rats, and cotton rats) and a prolonged period of post vaccination monitoring (41 days). Animals were directly inoculated orally with the vaccine and vaccine shedding was monitored using quantitative real-time PCR applied to oral and rectal swabs. ONRAB® DNA was detected in both oral and rectal swabs from 6 h to 3 days post-inoculation in most animals, followed by a resurgence of shedding between days 17 and 34 in some species. Overall, the duration over which ONRAB® DNA was detectable was shorter for non-target mammals, and by day 41, no animal had detectable DNA in either oral or rectal swabs. All target species, as well as cotton rats and laboratory-bred Norway rats, developed robust humoral immune responses as measured by competitive ELISA, with all individuals being seropositive at day 31. Similarly, opossums showed good response (89% seropositive; 8/9), whereas only one of nine wild caught Norway rats was seropositive at day 31. These results support findings of other safety studies suggesting that ONRAB® does not persist in vector and non-target mammals exposed to the vaccine. As such, we interpret these data to reflect a low risk of adverse effects to wild populations following distribution of ONRAB® to control sylvatic rabies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sobey KG, Jamieson SE, Walpole AA, et al. ONRAB® oral rabies vaccine is shed from, but does not persist in, captive mammals. Vaccine. 2019. PMID: 31248686. doi:10.1016/j.vaccine.2019.06.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。